# Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer

> **NCT07348887** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 50 (estimated)

## Conditions studied

- Squamous Cell Cancer of Head and Neck (SCCHN)

## Interventions

- **RADIATION:** Daily adaptive radiation therapy
- **RADIATION:** Image guided radiation therapy

## Key facts

- **NCT ID:** NCT07348887
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2029-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07348887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07348887, "Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07348887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*